Association of Anticancer Immune Checkpoint Inhibitors With Patient-Reported Outcomes Assessed in Randomized Clinical Trials: A Systematic Review and Meta-analysis

IMPORTANCE: The association of immune checkpoint inhibitors (ICIs) with patient quality of life has been poorly explored. OBJECTIVE: To evaluate patient-reported outcomes (PROs) assessed in randomized clinical trials (RCTs) of immunotherapy-based treatments. DATA SOURCES: This systematic review and...

Descripción completa

Detalles Bibliográficos
Autores principales: Pala, Laura, Sala, Isabella, Oriecuia, Chiara, De Pas, Tommaso, Queirolo, Paola, Specchia, Claudia, Cocorocchio, Emilia, Ferrucci, Pierfrancesco, Patanè, Damiano, Saponara, Maristella, Pennacchioli, Elisabetta, Coppola, Sara, Viale, Giuseppe, Giaccone, Giuseppe, Gelber, Richard D., Bagnardi, Vincenzo, Conforti, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382448/
https://www.ncbi.nlm.nih.gov/pubmed/35972744
http://dx.doi.org/10.1001/jamanetworkopen.2022.26252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382448/
https://www.ncbi.nlm.nih.gov/pubmed/35972744
http://dx.doi.org/10.1001/jamanetworkopen.2022.26252

Ejemplares similares